Medacta Group SA (SWX:MOVE)
113.60
-3.20 (-2.74%)
Sep 11, 2026, 5:30 PM CET
Medacta Group Market Cap
Medacta Group has a market cap or net worth of 2.27 billion as of September 11, 2026. Its market cap has decreased by -24.66% in one year.
Market Cap
2.27B
Enterprise Value
2.53B
Revenue
653.43M
Ranking
n/a
PE Ratio
31.79
Stock Price
113.60
ChartMarket Cap Chart
Since April 4, 2019, Medacta Group's market cap has increased from 1.92B to 2.27B, an increase of 17.89%. That is a compound annual growth rate of 2.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.27B | -27.36% |
| Dec 30, 2025 | 3.12B | 46.66% |
| Dec 30, 2024 | 2.13B | -15.15% |
| Dec 29, 2023 | 2.51B | 21.81% |
| Dec 30, 2022 | 2.06B | -27.53% |
| Dec 30, 2021 | 2.84B | 62.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 275.14B |
| Novartis AG | 212.96B |
| Lonza Group AG | 37.10B |
| Galderma Group AG | 36.13B |
| Ypsomed Holding AG | 4.65B |
| Galenica AG | 4.13B |
| Siegfried Holding AG | 3.10B |
| Tecan Group AG | 2.45B |